Elevated Glycosylated Chain Antigen CA19-9 Elevated CA19-9 Mainly Associated Tumors: pancreatic cancer, bile duct cancer, colorectal cancer. Other related tumors: liver cancer, gallbladder cancer, bile duct cancer, etc. Other influencing factors: Many patients with benign digestive system diseases, such as acute pancreatitis, cholestatic cholangitis, cholelithiasis, acute hepatitis, cirrhosis, etc., may also have different degrees of elevation of serum CA19-9. It is suggested that you should have regular review and consult with oncology specialists for diagnosis and treatment. Elevated carcinoembryonic antigen (CEA) Elevated carcinoembryonic antigen (CEA) is commonly found in lung cancer, colorectal cancer, pancreatic cancer, gastric cancer, breast cancer, medullary thyroid carcinoma and so on. Other influencing factors: smokers have more false positives, and serum CEA is also elevated in about 15-53% of pregnant women and patients with cardiovascular disease, diabetes mellitus, and non-specific colitis. It is recommended that you have a regular review and consultation with an oncologist. Elevated prostate-specific antigen (PSA) and glycosylated chain antigen CA125 (CA125) Elevated PSA is mainly seen in malignant tumors of the prostate and certain gynecological tumors and breast tumors. In addition, prostatitis and prostate hypertrophy can also cause elevation. CA125: Mainly associated tumors: ovarian cancer. Other cancers such as lung cancer, pancreatic cancer, breast cancer, liver cancer, gastrointestinal malignant tumor, uterine cancer can also be elevated. However, some related benign diseases and other factors, such as pelvic inflammatory disease, endometriosis, menstruation, ovarian cysts, uterine fibroids, chronic hepatitis, pancreatitis, cholecystitis, pneumonia, etc., will also increase CA125. It is recommended that you review the test in the following ways: First time: half a month later. Second time: 1 month after the first review. Then two consecutive monthly reviews. Then review 3 months and 6 months after the last review, respectively. If there is a progressive increase at a faster rate, please consult a specialist promptly. It is recommended that you review after 1 month and three consecutive times. If the increase is progressive and faster, please consult a specialist in time. Elevated Glycosylated Chain Antigen CA15-3 (CA15-3) The main tumor associated with elevated CA15-3 is breast cancer; other associated tumors: lung cancer, ovarian cancer, lung adenocarcinoma, colorectal cancer, etc. can be increased. Other influencing factors: benign breast disease, endometriosis, ovarian cysts, etc., the serum CA15-3 can also exceed the normal value. It is recommended that you have regular review and consultation with oncology specialists.